Results 91 to 100 of about 38,235 (163)

Recent Advances in Hafnium Oxide Nanomaterials: From Controlled Synthesis, Structure, and Surface Engineering to Biomedical Applications

open access: yesRare Metals, Volume 45, Issue 4, April 2026.
ABSTRACT Hafnium oxide (HfO2) nanoparticles (NPs), derived from a rare‐metal element, have gained increasing attention as a versatile class of functional nanostructures with unique optical, dielectric, and surface properties that enable diverse biomedical applications. As a representative rare‐metal oxide, HfO2 NPs with well‐defined architectures offer
Mothana Hussein Tarawneh   +8 more
wiley   +1 more source

Quantifying cancer epithelial-mesenchymal plasticity and its association with stemness and immune response

open access: yes, 2019
Cancer cells can acquire a spectrum of stable hybrid epithelial/mesenchymal (E/M) states during epithelial-mesenchymal transition (EMT). Cells in these hybrid E/M phenotypes often combine epithelial and mesenchymal features and tend to migrate ...
Bocci, Federico   +7 more
core   +1 more source

Novel Adamantane-Sclareol Hybrids Exploit ROS Vulnerability to Overcome Multidrug-Resistance in Glioblastoma Cells. [PDF]

open access: yesMolecules
Lupšić E   +9 more
europepmc   +1 more source

Mitochondrial connexin 43 modulates metabolic stress adaptation in glioma cell lines. [PDF]

open access: yesCell Commun Signal
Gervasi A   +10 more
europepmc   +1 more source

Feasibility and Safety of Autologous Dendritic Cell Vaccination Combined with Radio-Chemotherapy in Newly Diagnosed Glioblastoma: A Retrospective Single-Center Series. [PDF]

open access: yesVaccines (Basel)
Esparragosa Vázquez I   +13 more
europepmc   +1 more source

miR-181d coordinates homologous recombination and anti-tumor immune responses in glioblastoma. [PDF]

open access: yesiScience
Singh G   +18 more
europepmc   +1 more source

A Positive Feedback DNA-PK/MYT1L-CXCR1-ERK1/2 Proliferative Signaling Loop in Glioblastoma. [PDF]

open access: yesInt J Mol Sci
Wang B   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy